AstraZeneca Research Facilities - Bangalore, India

Go to navigation
Go to content

In June 2003, we opened new laboratories at our facility in Bangalore, India, dedicated to finding a new treatment for tuberculosis - the single largest cause of adult death from infectious disease in the world.

More than 70 scientists work in this new centre, including molecular biologists, genetic engineers and chemists.

The Bangalore scientists also work closely with AstraZeneca’s infection research centre in Boston, US and with external academic leaders in the field.

Not signed in

Page tools

Share price

London: 26.95 GBP
New York: 44.82 USD
Stockholm: 310.10 SEK

At 21-Nov-2009 03:08 GMT

Detailed share price

Introduction to AstraZeneca

Our responsibility

We continue to communicate openly on a range of issues, including:

Did you know

Contact us

Email enquiry form

This website is intended for people seeking information on the AstraZeneca International business. If you are in the US you should visit AstraZeneca US.

We also have national business sites which can be found under our list of AstraZeneca websites.

We also have specific national and international websites designed for patients and healthcare professionals. If you have a question you can contact us.